Actinium Pharmaceuticals, Inc. (ATNM)
NYSEAMERICAN: ATNM · Real-Time Price · USD
0.8900
-0.0299 (-3.25%)
Jul 16, 2026, 4:00 PM EDT - Market closed
Actinium Pharmaceuticals Market Cap
Actinium Pharmaceuticals has a market cap or net worth of $27.92 million as of July 16, 2026. Its market cap has decreased by -39.95% in one year.
Market Cap
27.92M
Enterprise Value
-12.69M
1-Year Change
-39.95%
Ranking
Category
Stock Price
$0.89
ChartMarket Cap Chart
Since December 27, 2012, Actinium Pharmaceuticals's market cap has increased from $16.70M to $27.92M, an increase of 67.21%. That is a compound annual growth rate of 3.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 16, 2026 | 27.90M | -34.20% |
| Dec 31, 2025 | 42.40M | 7.89% |
| Dec 31, 2024 | 39.30M | -71.79% |
| Dec 29, 2023 | 139.30M | -48.67% |
| Dec 30, 2022 | 271.40M | 104.98% |
| Dec 31, 2021 | 132.40M | 24.91% |
| Dec 31, 2020 | 106.00M | 195.26% |
| Dec 31, 2019 | 35.90M | -19.87% |
| Dec 31, 2018 | 44.80M | -15.63% |
| Dec 29, 2017 | 53.10M | 8.81% |
| Dec 30, 2016 | 48.80M | -64.04% |
| Dec 31, 2015 | 135.70M | -23.20% |
| Dec 31, 2014 | 176.70M | 26.85% |
| Dec 31, 2013 | 139.30M | 734.13% |
| Dec 31, 2012 | 16.70M | - |
| Dec 27, 2012 | 16.70M | - |
View and export this data all the way back to 2012. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Plus Therapeutics | 30.22M |
| Genenta Science | 29.96M |
| Kyntra Bio | 29.92M |
| Senti Biosciences Holdings | 29.90M |
| Tvardi Therapeutics | 29.55M |
| Polyrizon | 27.70M |
| GridAI Technologies | 27.31M |
| IGC Pharma | 26.98M |